Dr. Black has over 20 years of experience investigating osteoporosis and therapies to treat this disease. His most recent research involved the evaluation of treatments for osteoporosis and the risk of fracture. The study concluded that benefits of treatments outweigh the risk of rare femoral fractures. The results were published in early 2010 in the New England Journal of Medicine and received extensive media coverage. Dr. Black is currently Principal Investigator, along with Dr. Roberta Ballard, for a multi-center trial (TOLSURF) pioneering treatment for BPD (bronchopulmonary dysplasia) for extremely low birth weight infants.